7 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Unknown 7 |
Follow Hyperuricemia: new trials by email Literature Review of Hyperuricemia trials Research Report on Hyperuricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia Study Product A (High-dose 2X), Study Product B (Low-dose X), Placebo - Hyperuricemia | Not applicable | Unknown | Amway (China) R&D Center | 180 | 2023-10-23 | 2023-10-16 |
| Role of Uralyt-U in Patients With Hyperuricemia Febuxostat, Uralyt-U - Uric Acid Stones, Hyperuricemia | Not applicable | Unknown | Ai Peng | 102 | 2020-04-01 | 2020-04-20 |
| The Effects of Rhus Coriaria L. on Serum Uric Acid Levels Rhus (Somagh), Placebo - Hyperuricemia | Not applicable | Unknown | Shiraz University of Medical Sciences | 76 | 2019-06-01 | 2019-04-08 |
| Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial Probiotics, uric-acid-lowering drug - Gout, Hyperuricemia | Not applicable | Unknown | The Affiliated Hospital of Inner Mongolia Medical University | 300 | 2018-11-01 | 2023-07-20 |
| Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients Febuxostat, Benzbromarone - Chronic Kidney Disease, Hyperuricemia | Not applicable | Unknown | Shanghai 10th People's Hospital | 800 | 2016-10-01 | 2016-10-25 |
| Effect of Allopurinol Treatment on Insulin Resistance allopurinol 300 mg./day, No intervention, Normouricemic - Hyperuricemia, Prediabetes | Not applicable | Unknown | Istanbul Medeniyet University | 130 | 2013-12-01 | 2013-12-11 |
| Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy Febuxostat - Hyperuricemia | Not applicable | Unknown | Freed Study Group | 1000 | 2013-11-01 | 2016-08-26 |
Gout (1) · Insulin Resistance (1) · Prediabetic State (1) · Renal Insufficiency, Chronic (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Arthritis (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Crystal Arthropathies (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1)
Febuxostat (3) · Benzbromarone (1) · Citrates (1) · Probiotics (1)
Ai Peng (1) · Amway (China) R&D Center (1) · Freed Study Group (1) · Istanbul Medeniyet University (1) · Shanghai 10th People's Hospital (1) · Shiraz University of Medical Sciences (1) · The Affiliated Hospital of Inner Mongolia Medical University (1)
China (4) · Iran (1) · Japan (1) · Turkey (Türkiye) (1)
Ai Peng, MD, PhD (1) · Ai Peng, Ph.D., M.D. (1) · Ali Bakan (1) · Dan Cao, MD (1) · Gholamhossein Ranjbar Omrani, MD (1) · Hisao Ogawa (1) · Seiyed Mohammad Hosseini-Saadi, MD (1)
PMID 27005768, PMID 30844048, PMID 34605897, PMID 35648242, PMID 36261757, PMID 38389505